{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T22:32:43Z","timestamp":1788561163894,"version":"build-2803163510"},"reference-count":32,"publisher":"MDPI AG","issue":"4","license":[{"start":{"date-parts":[[2021,4,8]],"date-time":"2021-04-08T00:00:00Z","timestamp":1617840000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"National Institute of Health","award":["R01EY029823"],"award-info":[{"award-number":["R01EY029823"]}]},{"name":"Bright Focus Foundation","award":["G2018056"],"award-info":[{"award-number":["G2018056"]}]},{"name":"UNT Health Science Center-Applied Research Seed grant","award":["2400018"],"award-info":[{"award-number":["2400018"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Antioxidants"],"abstract":"<jats:p>Oxidative stress induced death and dysregulation of trabecular meshwork (TM) cells contribute to the increased intraocular pressure (IOP) in primary open angle (POAG) glaucoma patients. POAG is one of the major causes of irreversible vision loss worldwide. Nitric oxide (NO), a small gas molecule, has demonstrated IOP lowering activity in glaucoma by increasing aqueous humor outflow and relaxing TM. Glaucomatous pathology is associated with decreased antioxidant enzyme levels in ocular tissues causing increased reactive oxygen species (ROS) production that reduce the bioavailability of NO. Here, we designed, synthesized, and conducted in vitro studies of novel second-generation sulfur containing hybrid NO donor-antioxidants SA-9 and its active metabolite SA-10 to scavenge broad-spectrum ROS as well as provide efficient protection from t-butyl hydrogen peroxide (TBHP) induced oxidative stress while maintaining NO bioavailability in TM cells. To allow a better drug delivery, a slow release nanosuspension SA-9 nanoparticles (SA-9 NPs) was prepared, characterized, and tested in dexamethasone induced ocular hypertensive (OHT) mice model for IOP lowering activity. A single topical eye drop of SA-9 NPs significantly lowered IOP (61%) at 3 h post-dose, with the effect lasting up to 72 h. This class of molecule has high potential to be useful for treatment of glaucoma.<\/jats:p>","DOI":"10.3390\/antiox10040575","type":"journal-article","created":{"date-parts":[[2021,4,8]],"date-time":"2021-04-08T10:34:39Z","timestamp":1617878079000},"page":"575","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":28,"title":["Novel Thiol Containing Hybrid Antioxidant-Nitric Oxide Donor Small Molecules for Treatment of Glaucoma"],"prefix":"10.3390","volume":"10","author":[{"given":"Charles E.","family":"Amankwa","sequence":"first","affiliation":[{"name":"Department of Pharmacology and Neuroscience, University of North Texas Health Science Center, Fort Worth, TX 76107, USA"},{"name":"North Texas Eye Research Institute, University of North Texas Health Science Center, Fort Worth, TX 76107, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sudershan R.","family":"Gondi","sequence":"additional","affiliation":[{"name":"Department of Pharmacology and Neuroscience, University of North Texas Health Science Center, Fort Worth, TX 76107, USA"},{"name":"North Texas Eye Research Institute, University of North Texas Health Science Center, Fort Worth, TX 76107, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adnan","family":"Dibas","sequence":"additional","affiliation":[{"name":"Department of Pharmacology and Neuroscience, University of North Texas Health Science Center, Fort Worth, TX 76107, USA"},{"name":"North Texas Eye Research Institute, University of North Texas Health Science Center, Fort Worth, TX 76107, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Courtney","family":"Weston","sequence":"additional","affiliation":[{"name":"Department of Pharmacology and Neuroscience, University of North Texas Health Science Center, Fort Worth, TX 76107, USA"},{"name":"North Texas Eye Research Institute, University of North Texas Health Science Center, Fort Worth, TX 76107, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arlene","family":"Funk","sequence":"additional","affiliation":[{"name":"Department of Pharmacology and Neuroscience, University of North Texas Health Science Center, Fort Worth, TX 76107, USA"},{"name":"North Texas Eye Research Institute, University of North Texas Health Science Center, Fort Worth, TX 76107, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8338-7436","authenticated-orcid":false,"given":"Tam","family":"Nguyen","sequence":"additional","affiliation":[{"name":"Department of Bioengineering, University of Texas at Arlington, Arlington, TX 76010, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kytai T.","family":"Nguyen","sequence":"additional","affiliation":[{"name":"Department of Bioengineering, University of Texas at Arlington, Arlington, TX 76010, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dorette Z.","family":"Ellis","sequence":"additional","affiliation":[{"name":"North Texas Eye Research Institute, University of North Texas Health Science Center, Fort Worth, TX 76107, USA"},{"name":"Department of Pharmaceutical Sciences, College of Pharmacy, University of North Texas Health Science Center, Fort Worth, TX 76107, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5098-5555","authenticated-orcid":false,"given":"Suchismita","family":"Acharya","sequence":"additional","affiliation":[{"name":"Department of Pharmacology and Neuroscience, University of North Texas Health Science Center, Fort Worth, TX 76107, USA"},{"name":"North Texas Eye Research Institute, University of North Texas Health Science Center, Fort Worth, TX 76107, USA"},{"name":"Department of Pharmaceutical Sciences, College of Pharmacy, University of North Texas Health Science Center, Fort Worth, TX 76107, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2021,4,8]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1159\/000309104","article-title":"Intraocular Pressure Elevation\u2014Cause or Effect in Chronic Glaucoma?","volume":"182","author":"Krakau","year":"1981","journal-title":"Ophthalmol. J. Int. D\u2019Ophtalmologie Int. J. Ophthalmol. Z. Fur. Augenheilkd."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"295","DOI":"10.3109\/02713680903548970","article-title":"Oxidative stress markers in patients with primary open-angle glaucoma","volume":"35","author":"Ghanem","year":"2010","journal-title":"Curr. Eye Res."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1016\/j.ophtha.2004.12.035","article-title":"Noncompliance with ocular hypotensive treatment in patients with glaucoma or ocular hypertension an evidence-based review","volume":"112","author":"Olthoff","year":"2005","journal-title":"Ophthalmology"},{"key":"ref_4","doi-asserted-by":"crossref","unstructured":"Reina-Torres, E., De Ieso, M.L., Pasquale, L.R., Madekurozwaa, M., van Batenburg-Sherwooda, J., Overby, D.R., and Stamer, W.D. (2020). The vital role for nitric oxide in intraocular pressure homeostasis. Prog. Retin. Eye Res., in press.","DOI":"10.1016\/j.preteyeres.2020.100922"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"2035","DOI":"10.2147\/OPTH.S103985","article-title":"Critical evaluation of latanoprostene bunod in the treatment of glaucoma","volume":"10","author":"Garcia","year":"2016","journal-title":"Clin. Ophthalmol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/j.jvs.2013.03.023","article-title":"The essential role of endothelial nitric oxide synthase activation in insulin-mediated neuroprotection against ischemic stroke in diabetes","volume":"59","author":"Huang","year":"2014","journal-title":"J. Vasc. Surg."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"194","DOI":"10.4103\/2045-9912.215750","article-title":"The role of nitric oxide in stroke","volume":"7","author":"Chen","year":"2017","journal-title":"Med. Gas Res."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"713","DOI":"10.3109\/02713683.2011.584370","article-title":"Antioxidant status and oxidative stress in primary open angle glaucoma and pseudoexfoliative glaucoma","volume":"36","author":"Erdurmus","year":"2011","journal-title":"Curr. Eye Res."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"75","DOI":"10.3389\/fneur.2012.00075","article-title":"Preclinical Models to Investigate Retinal Ischemia: Advances and Drawbacks","volume":"3","author":"Minhas","year":"2012","journal-title":"Front. Neurol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1016\/j.bmcl.2015.12.030","article-title":"Design and synthesis of novel hybrid sydnonimine and prodrug useful for glaucomatous optic neuropathy","volume":"26","author":"Acharya","year":"2016","journal-title":"Bioorganic Med. Chem. Lett."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"3064","DOI":"10.1167\/iovs.18-25999","article-title":"Hybrid Compound SA-2 is Neuroprotective in Animal Models of Retinal Ganglion Cell Death","volume":"60","author":"Stankowska","year":"2019","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"ref_12","first-page":"37","article-title":"Nanoencapsulated hybrid compound SA-2 with long-lasting intraocular pressure lowering activity in rodent eyes","volume":"27","author":"Stankowska","year":"2021","journal-title":"Mol. Vis."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"1808","DOI":"10.1167\/iovs.08-2750","article-title":"Characterization of Soluble Guanylate Cyclase in NO-Induced Increases in Aqueous Humor Outflow Facility and in the Trabecular Meshwork","volume":"50","author":"Ellis","year":"2009","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.aca.2013.07.027","article-title":"Superoxide generated by pyrogallol reduces highly water-soluble tetrazolium salt to produce a soluble formazan: A simple assay for measuring superoxide anion radical scavenging activities of biological and abiological samples","volume":"793","author":"Xu","year":"2013","journal-title":"Anal. Chim. Acta"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1006\/abio.1994.1195","article-title":"A method for screening hypochlorous acid scavengers by inhibition of the oxidation of 5-thio-2-nitrobenzoic acid: Application to anti-asthmatic drugs","volume":"218","author":"Ching","year":"1994","journal-title":"Anal. Biochem."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"8692","DOI":"10.1038\/s41598-017-08441-9","article-title":"Hybrid Nitric Oxide Donor and its Carrier for the Treatment of Peripheral Arterial Diseases","volume":"7","author":"Le","year":"2017","journal-title":"Sci. Rep."},{"key":"ref_17","first-page":"1361","article-title":"The ocular toxicity and pharmacokinetics of simvastatin following intravitreal injection in mice","volume":"10","author":"Tse","year":"2017","journal-title":"Int. J. Ophthalmol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1016\/j.ajpath.2016.12.003","article-title":"Dexamethasone-Induced Ocular Hypertension in Mice: Effects of Myocilin and Route of Administration","volume":"187","author":"Patel","year":"2017","journal-title":"Am. J. Pathol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"9854","DOI":"10.1074\/jbc.RA118.002540","article-title":"Transforming growth factor \u03b22 (TGF\u03b22) signaling plays a key role in glucocorticoid-induced ocular hypertension","volume":"293","author":"Kasetti","year":"2018","journal-title":"J. Biol. Chem."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"2028","DOI":"10.1161\/01.ATV.0000143388.20994.fa","article-title":"Hypochlorous acid impairs endothelium-derived nitric oxide bioactivity through a superoxide-dependent mechanism","volume":"24","author":"Stocker","year":"2004","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.ab.2017.01.001","article-title":"Fluorescent real-time quantitative measurements of intracellular peroxynitrite generation and inhibition","volume":"520","author":"Luo","year":"2017","journal-title":"Anal. Biochem."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"1956","DOI":"10.1172\/JCI69774","article-title":"Ocular-specific ER stress reduction rescues glaucoma in murine glucocorticoid-induced glaucoma","volume":"124","author":"Zode","year":"2014","journal-title":"J. Clin. Investig."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"5594","DOI":"10.1038\/s41467-020-19352-1","article-title":"ATF4 leads to glaucoma by promoting protein synthesis and ER client protein load","volume":"11","author":"Kasetti","year":"2020","journal-title":"Nat. Commun."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.ijcard.2004.01.007","article-title":"Efficacy and safety of molsidomine once-a-day in patients with stable angina pectoris","volume":"98","author":"Messin","year":"2005","journal-title":"Int. J. Cardiol."},{"key":"ref_25","first-page":"1711","article-title":"Decreased intraocular pressure induced by nitric oxide donors is correlated to nitrite production in the rabbit eye","volume":"37","author":"Goureau","year":"1996","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1007\/s007260200020","article-title":"Effects of sulfur containing amino acids on iron and nitric oxide stimulated catecholamine oxidation","volume":"22","author":"Biasetti","year":"2002","journal-title":"Amino Acids"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1016\/S0891-5849(03)00437-4","article-title":"The metabolism of sulindac enhances its scavenging activity against reactive oxygen and nitrogen species","volume":"35","author":"Fernandes","year":"2003","journal-title":"Free Radic. Biol. Med."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1007\/s11172-018-2125-4","article-title":"Sulfur-containing phenolic antioxidants increasing antitumor efficiency of cyclophosphamide and its combination with nitric oxide donor","volume":"67","author":"Bogatyrenko","year":"2018","journal-title":"Russ. Chem. Bull."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"2408","DOI":"10.1016\/j.ccr.2005.03.021","article-title":"Interplay between iron complexes, nitric oxide and sulfur ligands: Structure, (photo)reactivity and biological importance","volume":"249","author":"Chmura","year":"2005","journal-title":"Coord. Chem. Rev."},{"key":"ref_30","doi-asserted-by":"crossref","unstructured":"S\u00e1nchez L\u00f3pez, E. (2019). Recent advances in nanoscopic drug delivery systems for the treatment of glaucoma. Acta Ophthalmol., 97.","DOI":"10.1111\/j.1755-3768.2019.5009"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/j.colsurfb.2014.07.004","article-title":"Dorzolamide-loaded PLGA\/vitamin E TPGS nanoparticles for glaucoma therapy: Pharmacoscintigraphy study and evaluation of extended ocular hypotensive effect in rabbits","volume":"122","author":"Warsi","year":"2014","journal-title":"Colloids Surf. B Biointerfaces"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/j.ajps.2017.03.002","article-title":"Feasibility of drug delivery to the eye\u2019s posterior segment by topical instillation of PLGA nanoparticles","volume":"12","author":"Tahara","year":"2017","journal-title":"Asian J. Pharm. Sci."}],"container-title":["Antioxidants"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2076-3921\/10\/4\/575\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,13]],"date-time":"2025-10-13T13:26:40Z","timestamp":1760362000000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2076-3921\/10\/4\/575"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4,8]]},"references-count":32,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2021,4]]}},"alternative-id":["antiox10040575"],"URL":"https:\/\/doi.org\/10.3390\/antiox10040575","relation":{},"ISSN":["2076-3921"],"issn-type":[{"value":"2076-3921","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,4,8]]}}}